The United States Food and Drug Administration (FDA) has announced a brief extension to its re-review of the partial clinical hold on Vanda Pharmaceuticals’ investigational drug,...
Novo Nordisk plans to launch an oral version of its highly successful weight loss medication, Wegovy (semaglutide), pending approval from the United States Food and Drug...
FluidAI Medical has achieved a significant milestone by obtaining clearance from the United States Food and Drug Administration (FDA) for its innovative device designed to predict...
